Peddock Capital Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$235K Hold
2,723
– – 0.05% 149
2026
Q2
$213K Hold
2,723
– – 0.04% 159
2026
Q1
$236K Hold
2,723
– – 0.05% 149
2025
Q4
$262K Hold
2,723
– – 0.05% 140
2025
Q3
$259K Hold
2,723
– – 0.06% 142
2025
Q2
$237K Buy
2,723
+75
+3% +$6.36K 0.05% 150
2025
Q1
$238K Buy
2,648
+141
+6% +$12.6K 0.06% 144
2024
Q4
$200K Buy
+2,507
New +$217K 0.05% 156
2022
Q4
– Sell
-6,294
Closed -$508K – 145
2022
Q3
$508K Buy
6,294
+287
+5% +$25.8K 0.21% 104
2022
Q2
$539K Buy
6,007
+329
+6% +$33.3K 0.21% 104
2022
Q1
$630K Buy
+5,678
New +$600K 0.2% 104

Other funds holding MDT

Peddock Capital Advisors's MDT Position: Q3 2026 in Review

Peddock Capital Advisors held its Medtronic (MDT) position steady in Q3 2026 at 2,723 shares worth $235K. The position accounts for 0.05% of the portfolio, ranked #149.

Peddock Capital Advisors first reported a position in MDT in Q1 2022 and has held it in 11 quarters since. The position peaked at $630K in Q1 2022. 2,203 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Peddock Capital Advisors held 2,723 shares of Medtronic worth $235K as of Q3 2026.
  • Peddock Capital Advisors left its Medtronic share count unchanged in Q3 2026.
  • Medtronic made up 0.05% of Peddock Capital Advisors's portfolio in Q3 2026, its #149 holding.
  • Peddock Capital Advisors first reported a position in Medtronic in Q1 2022 and has held it in 11 quarters since.
  • Peddock Capital Advisors's Medtronic position peaked at $630K in Q1 2022.
  • 2,203 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Peddock Capital Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.